Serogroup A meningococcal conjugate (PsA-TT) vaccine coverage and measles vaccine coverage in Burkina Faso—Implications for introduction of PsA-TT into the Expanded Programme on Immunization

BACKGROUND: A new serogroup A meningococcal conjugate vaccine (PsA-TT, MenAfriVac™) has been developed to combat devastating serogroup A Neisseria meningitis (MenA) epidemics in Africa. A mass immunization campaign targeting 1–29 year olds was conducted in Burkina Faso in December 2010. Protection o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Vaccine
Main Authors: Meyer, Sarah A., Kambou, Jean Ludovic, Cohn, Amanda, Goodson, James L., Flannery, Brendan, Medah, Isaïe, Messonnier, Nancy, Novak, Ryan, Diomande, Fabien, Djingarey, Mamoudou H., Clark, Thomas A., Yameogo, Issaka, Fall, Amadou, Wannemuehler, Kathleen
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5755366/
https://ncbi.nlm.nih.gov/pubmed/25636915
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2015.01.043
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados